Treatment patterns in pediatric patients with multiple sclerosis in Germany-a nationwide claim-based analysis.

ABSTRACT:

Background

The manifestation of multiple sclerosis (MS) in childhood and adolescence occurs in 3%-5% of all MS cases. However, the immunomodulatory and symptomatic treatment options in this population group are still limited.

Objective

We aimed to elucidate the prescription frequency of medications used in pediatric patients with multiple sclerosis (PwMS) compared with the general population, considering the entire spectrum of medications prescribed.

Methods

Based on nationwide outpatient drug prescription data and statutory health insurance (SHI) physicians' claims data from 2018, we conducted a population-based cross-sectional study in Germany. Children and adolescents aged ⩽17 years (n = 11,381,939) diagnosed with MS (n = 613), and a matched (age, sex

SUBMITTER: Frahm N 

PROVIDER: S-EPMC8504210 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature